Insulin modulation of glucagon secretion The role of insulin and other factors in the regulation of glucagon secretion

被引:26
作者
Kawamori, Dan
Kulkarni, Rohit N. [1 ]
机构
[1] Harvard Univ, Sch Med, Dept Cellular & Mol Physiol, Joslin Diabet Ctr, Boston, MA 02115 USA
关键词
glucagon; insulin; insulin receptor; hypoglycemia; somatostatin;
D O I
10.4161/isl.1.3.9967
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glucagon plays a critical counter-regulatory role to insulin to maintain optimal glucose homeostasis. Glucagon secretion from pancreatic α-cells is regulated by glycemia, neural input, and secretion from neighboring β-cells. Recently, we provided direct genetic evidence of a critical role for insulin signaling in the regulation of glucagon secretion in vivo. Pancreatic α-cell targeted disruption of insulin receptor expression in mice resulted in glucose intolerance, hyperglycemia and hyperglucagonemia coupled with an abnormal glucagon response to hypoglycemia. Furthermore, streptozotocin treated mice exhibited paradoxically increased plasma glucagon suggesting a dominant role for insulin in the regulation of glucagon secretion compared with glucose. In fact, normalization of hyperglycemia by phrolidzin treatment decreased plasma glucagon levels suggesting a stimulatory effect of glucose on glucagon secretion and also revealed the significance of insulin in hyperglycemic states. Together these studies provide novel insights into intra-islet regulatory pathways in the modulation of glucagon secretion and provide potential opportunities to develop therapeutic approaches for the correction of α-cell dysfunction in diabetes.
引用
收藏
页码:276 / 279
页数:4
相关论文
共 35 条
[1]   Autonomic regulation of islet hormone secretion -: Implications for health and disease [J].
Ahrén, B .
DIABETOLOGIA, 2000, 43 (04) :393-410
[2]   Impaired glucose tolerance (IGT) is associated with reduced insulin-induced suppression of glucagon concentrations [J].
Ahrén, B ;
Larsson, H .
DIABETOLOGIA, 2001, 44 (11) :1998-2003
[3]   INVIVO INHIBITION OF GLUCAGON-SECRETION BY PARACRINE BETA-CELL ACTIVITY IN MAN [J].
ASPLIN, CM ;
PAQUETTE, TL ;
PALMER, JP .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (01) :314-318
[4]   INSULIN, GLUCAGON, AND SOMATOSTATIN RECEPTORS ON CULTURED-CELLS AND CLONES FROM RAT ISLET CELL TUMOR [J].
BHATHENA, SJ ;
OIE, HK ;
GAZDAR, AF ;
VOYLES, NR ;
WILKINS, SD ;
RECANT, L .
DIABETES, 1982, 31 (06) :521-531
[5]   ROLE OF AUTONOMIC NERVOUS-SYSTEM IN CONTROL OF GLUCAGON, INSULIN AND PANCREATIC POLYPEPTIDE RELEASE FROM PANCREAS [J].
BLOOM, SR ;
EDWARDS, AV ;
HARDY, RN .
JOURNAL OF PHYSIOLOGY-LONDON, 1978, 280 (JUL) :9-23
[6]   Hypoglycaemia: The limiting factor in the glycaemic management of Type I and Type II Diabetes [J].
Cryer, PE .
DIABETOLOGIA, 2002, 45 (07) :937-948
[7]   Glucose-regulated glucagon secretion requires insulin receptor expression in pancreatic α-cells [J].
Diao, JY ;
Asghar, Z ;
Chan, CB ;
Wheeler, MB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (39) :33487-33496
[8]   β-Cell secretory products activate α-cell ATP-dependent potassium channels to inhibit glucagon release [J].
Franklin, I ;
Gromada, J ;
Gjinovci, A ;
Theander, S ;
Wollheim, CB .
DIABETES, 2005, 54 (06) :1808-1815
[9]   NORMALIZATION OF FASTING HYPERGLUCAGONEMIA AND EXCESSIVE GLUCAGON RESPONSES TO INTRAVENOUS ARGININE IN HUMAN DIABETES-MELLITUS BY PROLONGED INFUSION OF INSULIN [J].
GERICH, JE ;
TSALIKIAN, E ;
LORENZI, M ;
SCHNEIDER, V ;
BOHANNON, NV ;
GUSTAFSON, G ;
KARAM, JH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1975, 41 (06) :1178-1180
[10]   ROLE OF SOMATOSTATIN AND ITS ANALOGS IN THE PATHOGENESIS AND TREATMENT OF DIABETES-MELLITUS [J].
GERICH, JE .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1990, 39 (09) :52-54